Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

CARSTEN NIEDER; SIV GYDA AANES; ELLINOR C. HAUKLAND

doi:10.21873/anticanres.15793

Research ArticleClinical Studies

Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND

Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793

CARSTEN NIEDER

1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;

2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: carsten.nieder{at}nlsh.no

SIV GYDA AANES

1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ELLINOR C. HAUKLAND

1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;

3SHARE – Center for Resilience in Healthcare, Faculty of Health Sciences, Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Actuarial overall survival for three different settings, p=0.01 (pooled over all strata).

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 42, Issue 6

June 2022

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 9 + 4 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

CARSTEN NIEDER, SIV GYDA AANES, ELLINOR C. HAUKLAND

Anticancer Research Jun 2022, 42 (6) 3061-3066; DOI: 10.21873/anticanres.15793

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

CARSTEN NIEDER, SIV GYDA AANES, ELLINOR C. HAUKLAND

Anticancer Research Jun 2022, 42 (6) 3061-3066; DOI: 10.21873/anticanres.15793

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation

Google Scholar

Keywords

non-small cell lung cancer
malignant melanoma
kidney cancer
systemic therapy
immune checkpoint inhibitor

Main menu

User menu

Search

Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords